Abstract
Summary
Human hepatitis A virus, partially purified from the liver of a rufiventer marmoset infected with CR326 strain virus, was inactivated with formalin and was shown to be highly potent in stimulating homologous antibody in marmosets when administered subcutaneously at bi-weekly intervals in eight divided doses. The vaccine was shown to prevent hepatitis A in all marmosets when challenged with live hepatitis A virus in a controlled study.
Get full access to this article
View all access options for this article.